---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-26-004419"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:47:40.844948+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Zomedica Q1 revenue record $8.8M, up 35% YoY; net loss narrows to $4.5M

## Summary
- Record Q1 revenue $8.8M, up 35% from $6.5M in Q1 2025; 21st straight quarter of YoY growth.
- Diagnostics segment revenue $1.0M, +73% YoY; Therapeutic Devices $5.8M flat; Development Services $2.0M.
- Net loss $4.5M vs $63.8M in prior year which included $55.8M impairment; Adjusted EBITDA loss improved 58% to $2.4M.
- Cash burn reduced 15% to $5.7M; liquidity $47.5M as of March 31, 2026.
- Launched TRUVIEW AI telepathology platform and announced collaboration with Boehringer Ingelheim for equine PPID testing.

## SEC filing metadata
- accession: 0001654954-26-004419
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495426004419/0001654954-26-004419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495426004419/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-26-004419
- JSON: https://secwatch.observer/filing/0001654954-26-004419.json
- Plain text: https://secwatch.observer/filing/0001654954-26-004419.txt

## Source-grounded claims
- claim_id: b01e4d894e22f22f819c0d3b9dc813d75cd3af66
  claim: Zomedica Corp. reported the first quarter ended March 31, 2026 results: revenue $8.8 million.
  evidence_excerpt: Zomedica Announces Record First Quarter Revenue of $8.8 Million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495426004419/0001654954-26-004419-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.